SACUBITRIL CALCIUM SALTS

The invention relates to polymorphic forms of the calcium salt of N-(3-carboxyl-1-oxopropyl)-(4S)-(p-phenylphenylmethyl)-4-amino-(2R)-methyl butanoic acid ethyl ester. The calcium salt of N-(3-carboxyl-1-oxopropyl)-(4S)-(p-phenylphenylmethyl)-4-amino-(2R)-methyl butanoic acid ethyl ester is useful i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: WAYKOLE LILADHAR MURLIDHAR, SUTTON PAUL ALLEN, KLEINBECK FLORIAN KARL, WIETFELD BERNHARD, MEIER ULRICH, HOOK DAVID, MUTZ JEAN-PAUL, MUELLER SIBYLLE, SCHLOMACH JAN, HU BIN
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator WAYKOLE LILADHAR MURLIDHAR
SUTTON PAUL ALLEN
KLEINBECK FLORIAN KARL
WIETFELD BERNHARD
MEIER ULRICH
HOOK DAVID
MUTZ JEAN-PAUL
MUELLER SIBYLLE
SCHLOMACH JAN
HU BIN
description The invention relates to polymorphic forms of the calcium salt of N-(3-carboxyl-1-oxopropyl)-(4S)-(p-phenylphenylmethyl)-4-amino-(2R)-methyl butanoic acid ethyl ester. The calcium salt of N-(3-carboxyl-1-oxopropyl)-(4S)-(p-phenylphenylmethyl)-4-amino-(2R)-methyl butanoic acid ethyl ester is useful in the treatment of various conditions and disorders responsive to the inhibition of neutral endopeptidases. 本发明涉及N-(3-羧基-1-氧丙基)-(4S)-(对苯基苯基甲基)-4-氨基-(2R)-甲基丁酸乙酯钙盐的多晶型。N-(3-羧基-1-氧丙基)-(4S)-(对苯基苯基甲基)-4-氨基-(2R)-甲基丁酸乙酯的钙盐用于治疗响应中性内肽酶抑制的多种病症和紊乱。
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN107980038A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN107980038A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN107980038A3</originalsourceid><addsrcrecordid>eNrjZJAIdnQOdfIMCfL0UXB29HH2DPVVCHb0CQnmYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxzn6GBuaWFgYGxhaOxsSoAQD18B--</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>SACUBITRIL CALCIUM SALTS</title><source>esp@cenet</source><creator>WAYKOLE LILADHAR MURLIDHAR ; SUTTON PAUL ALLEN ; KLEINBECK FLORIAN KARL ; WIETFELD BERNHARD ; MEIER ULRICH ; HOOK DAVID ; MUTZ JEAN-PAUL ; MUELLER SIBYLLE ; SCHLOMACH JAN ; HU BIN</creator><creatorcontrib>WAYKOLE LILADHAR MURLIDHAR ; SUTTON PAUL ALLEN ; KLEINBECK FLORIAN KARL ; WIETFELD BERNHARD ; MEIER ULRICH ; HOOK DAVID ; MUTZ JEAN-PAUL ; MUELLER SIBYLLE ; SCHLOMACH JAN ; HU BIN</creatorcontrib><description>The invention relates to polymorphic forms of the calcium salt of N-(3-carboxyl-1-oxopropyl)-(4S)-(p-phenylphenylmethyl)-4-amino-(2R)-methyl butanoic acid ethyl ester. The calcium salt of N-(3-carboxyl-1-oxopropyl)-(4S)-(p-phenylphenylmethyl)-4-amino-(2R)-methyl butanoic acid ethyl ester is useful in the treatment of various conditions and disorders responsive to the inhibition of neutral endopeptidases. 本发明涉及N-(3-羧基-1-氧丙基)-(4S)-(对苯基苯基甲基)-4-氨基-(2R)-甲基丁酸乙酯钙盐的多晶型。N-(3-羧基-1-氧丙基)-(4S)-(对苯基苯基甲基)-4-氨基-(2R)-甲基丁酸乙酯的钙盐用于治疗响应中性内肽酶抑制的多种病症和紊乱。</description><language>chi ; eng</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2018</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20180501&amp;DB=EPODOC&amp;CC=CN&amp;NR=107980038A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20180501&amp;DB=EPODOC&amp;CC=CN&amp;NR=107980038A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>WAYKOLE LILADHAR MURLIDHAR</creatorcontrib><creatorcontrib>SUTTON PAUL ALLEN</creatorcontrib><creatorcontrib>KLEINBECK FLORIAN KARL</creatorcontrib><creatorcontrib>WIETFELD BERNHARD</creatorcontrib><creatorcontrib>MEIER ULRICH</creatorcontrib><creatorcontrib>HOOK DAVID</creatorcontrib><creatorcontrib>MUTZ JEAN-PAUL</creatorcontrib><creatorcontrib>MUELLER SIBYLLE</creatorcontrib><creatorcontrib>SCHLOMACH JAN</creatorcontrib><creatorcontrib>HU BIN</creatorcontrib><title>SACUBITRIL CALCIUM SALTS</title><description>The invention relates to polymorphic forms of the calcium salt of N-(3-carboxyl-1-oxopropyl)-(4S)-(p-phenylphenylmethyl)-4-amino-(2R)-methyl butanoic acid ethyl ester. The calcium salt of N-(3-carboxyl-1-oxopropyl)-(4S)-(p-phenylphenylmethyl)-4-amino-(2R)-methyl butanoic acid ethyl ester is useful in the treatment of various conditions and disorders responsive to the inhibition of neutral endopeptidases. 本发明涉及N-(3-羧基-1-氧丙基)-(4S)-(对苯基苯基甲基)-4-氨基-(2R)-甲基丁酸乙酯钙盐的多晶型。N-(3-羧基-1-氧丙基)-(4S)-(对苯基苯基甲基)-4-氨基-(2R)-甲基丁酸乙酯的钙盐用于治疗响应中性内肽酶抑制的多种病症和紊乱。</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2018</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJAIdnQOdfIMCfL0UXB29HH2DPVVCHb0CQnmYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxzn6GBuaWFgYGxhaOxsSoAQD18B--</recordid><startdate>20180501</startdate><enddate>20180501</enddate><creator>WAYKOLE LILADHAR MURLIDHAR</creator><creator>SUTTON PAUL ALLEN</creator><creator>KLEINBECK FLORIAN KARL</creator><creator>WIETFELD BERNHARD</creator><creator>MEIER ULRICH</creator><creator>HOOK DAVID</creator><creator>MUTZ JEAN-PAUL</creator><creator>MUELLER SIBYLLE</creator><creator>SCHLOMACH JAN</creator><creator>HU BIN</creator><scope>EVB</scope></search><sort><creationdate>20180501</creationdate><title>SACUBITRIL CALCIUM SALTS</title><author>WAYKOLE LILADHAR MURLIDHAR ; SUTTON PAUL ALLEN ; KLEINBECK FLORIAN KARL ; WIETFELD BERNHARD ; MEIER ULRICH ; HOOK DAVID ; MUTZ JEAN-PAUL ; MUELLER SIBYLLE ; SCHLOMACH JAN ; HU BIN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN107980038A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2018</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>WAYKOLE LILADHAR MURLIDHAR</creatorcontrib><creatorcontrib>SUTTON PAUL ALLEN</creatorcontrib><creatorcontrib>KLEINBECK FLORIAN KARL</creatorcontrib><creatorcontrib>WIETFELD BERNHARD</creatorcontrib><creatorcontrib>MEIER ULRICH</creatorcontrib><creatorcontrib>HOOK DAVID</creatorcontrib><creatorcontrib>MUTZ JEAN-PAUL</creatorcontrib><creatorcontrib>MUELLER SIBYLLE</creatorcontrib><creatorcontrib>SCHLOMACH JAN</creatorcontrib><creatorcontrib>HU BIN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>WAYKOLE LILADHAR MURLIDHAR</au><au>SUTTON PAUL ALLEN</au><au>KLEINBECK FLORIAN KARL</au><au>WIETFELD BERNHARD</au><au>MEIER ULRICH</au><au>HOOK DAVID</au><au>MUTZ JEAN-PAUL</au><au>MUELLER SIBYLLE</au><au>SCHLOMACH JAN</au><au>HU BIN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>SACUBITRIL CALCIUM SALTS</title><date>2018-05-01</date><risdate>2018</risdate><abstract>The invention relates to polymorphic forms of the calcium salt of N-(3-carboxyl-1-oxopropyl)-(4S)-(p-phenylphenylmethyl)-4-amino-(2R)-methyl butanoic acid ethyl ester. The calcium salt of N-(3-carboxyl-1-oxopropyl)-(4S)-(p-phenylphenylmethyl)-4-amino-(2R)-methyl butanoic acid ethyl ester is useful in the treatment of various conditions and disorders responsive to the inhibition of neutral endopeptidases. 本发明涉及N-(3-羧基-1-氧丙基)-(4S)-(对苯基苯基甲基)-4-氨基-(2R)-甲基丁酸乙酯钙盐的多晶型。N-(3-羧基-1-氧丙基)-(4S)-(对苯基苯基甲基)-4-氨基-(2R)-甲基丁酸乙酯的钙盐用于治疗响应中性内肽酶抑制的多种病症和紊乱。</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language chi ; eng
recordid cdi_epo_espacenet_CN107980038A
source esp@cenet
subjects ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title SACUBITRIL CALCIUM SALTS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T09%3A50%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=WAYKOLE%20LILADHAR%20MURLIDHAR&rft.date=2018-05-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN107980038A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true